{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:47:43Z","timestamp":1649123263847},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.transci.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T18:50:23Z","timestamp":1419015023000},"page":"65-71","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beta-2 microglobulin predicts the outcome after autologous stem cell transplantation in non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Elif Birtas","family":"Atesoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Hac\u0131hanefioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafer","family":"Gulbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2014.12.007_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbmt.2011.09.009","article-title":"The evolving role of stem cell transplants in lymphomas","volume":"18","author":"Jantunen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2014.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2014.12.007_bib0020","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2014.12.007_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2014.12.007_bib0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2008.05.002","article-title":"Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma","volume":"14","author":"Wildes","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2014.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.11173","article-title":"The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing\/refractory peripheral T-cell lymphoma","volume":"92","author":"Rodr\u00edguez","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2014.12.007_bib0040","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1084\/jem.138.6.1608","article-title":"The small subunit of HL-A antigens is beta 2-microglobulin","volume":"138","author":"Grey","year":"1973","journal-title":"J Exp Med"},{"key":"10.1016\/j.transci.2014.12.007_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000362670","article-title":"Prognostic significance of serum Beta-2 microglobulin in patients with non-Hodgkin lymphoma","volume":"87","author":"Wu","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.transci.2014.12.007_bib0050","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2002-09-2924","article-title":"Regulation of human beta 2-microglobulin transactivation in hematopoietic cells","volume":"101","author":"Gobin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transci.2014.12.007_bib0055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1365-2141.1996.437976.x","article-title":"The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups","volume":"92","author":"Prince","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2014.12.007_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2141.2001.02955.x","article-title":"Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma","volume":"114","author":"Cortelazzo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2014.12.007_bib0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ajh.23108","article-title":"Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity","volume":"87","author":"Elstrom","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2014.12.007_bib0070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/bmt.2010.188","article-title":"Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma","volume":"46","author":"Plattel","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2014.12.007_bib0075","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/annonc\/mdm608","article-title":"High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age","volume":"19","author":"Hosing","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2014.12.007_bib0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin's lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2014.12.007_bib0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2141.2006.06232.x","article-title":"Absolute lymphocyte count predicts overall survival in follicular lymphomas","volume":"134","author":"Siddiqui","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T17:27:29Z","timestamp":1537982849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050214002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1473050214002456"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.007","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-2 microglobulin predicts the outcome after autologous stem cell transplantation in non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}